Portfolio company
Kincell Bio
United States · £17.4m raised
Raised
£17.4m
Latest stage
Growth
Rounds recorded
1
Backed by
1 investor
Sectors
About
The company provides manufacturing, analytical development and regulatory services for cell therapy developers from early clinical stages through to commercial launch.
SourceFunding history · 1
Similar companies
Kincell Bio
This company provides cell therapy manufacturing, analytical development and regulatory strategy services for biotechnology firms from early development through to commercial supply.
AdThera
The company provides process development and manufacturing services for cell and gene therapies to biotechnology firms and academic centres.
PharmaCell
The company provides contract manufacturing and development services for cell and gene therapy products to pharmaceutical and biotechnology clients.
ViroCell
The company designs and manufactures viral vectors for academic and corporate innovators developing cell and gene therapies for clinical trials.
AmplifyBio
This company provides contract research and manufacturing services for cell and gene therapy developers to accelerate drug discovery and clinical development.
Ascend Advanced Therapies
The company provides development and manufacturing services for gene therapy products to life science innovators and pharmaceutical businesses.
Cellero
The company provides human-derived biomaterials and laboratory services to researchers and manufacturers developing cell and gene therapies.
Stemmaters
The company provides development and manufacturing services for regenerative medicine and cell therapy products to biotechnology and pharmaceutical clients.
